Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.
This study has been completed.
Study NCT00338624 Information provided by McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
First Received on June 16, 2006. Last Updated on May 20, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Adrenergic alpha-1 Receptor Antagonists
Anti-Infective Agents, Urinary
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sponsors listed in this trial
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers